In hepatocellular carcinoma (HCC), doxorubicin chemoresistance occurs through epithelial mesenchymal transition (EMT) induction, with vimentin upregulation and downregulation of E-cadherin and claudin1 EMT-associated proteins. Here, VIM is linked to hepatocellular carcinoma.